go to the Annual Report homepage
  Letter to Shareholders Financial Highlights Progress Toward Growth Goals Portfolio Mix
 














One reason for our success in 2000 is the balance in Ferro's mix of businesses, which allowed us to deliver continued growth while many companies in our industry fell short of expectations. Only a portion of our businesses are dependent on petroleum-based raw materials, so changes in those costs have a smaller impact on Ferro's overall performance than on some other specialty chemical companies, and our strong international presence helps us balance the impact of economic cycles worldwide. Our focus remains on improving the balance of our portfolio and taking advantage of the opportunities in our target markets. We are confident that sales and earnings will reflect the success of these efforts long-term.


We continue to believe that our stock deserves a much higher valuation than the level at which we ended 2000; however, the 5 percent increase in value of Ferro shares in 2000 compared favorably with the Standard and Poor's Mid-Cap Chemicals Index. Ferro also outperformed the Standard and Poor's 500 Index, one of the broadest market measures, which ended 2000 down 10 percent. Therefore, on a relative basis, Ferro stock performed fairly well in 2000.


Our long-term strategic growth plan remains solid and by executing that plan, we are confident we will be rewarded with a higher stock price. We made significant progress with our plan for growth in 2000. Recent acquisitions have improved our position in growing businesses. Continued strength in many of our core businesses has contributed to internal growth. We are expanding our manufacturing capacity in several key markets around the world. And, under the management strategy we call our "Leadership Agenda," we are aggressively reshaping our portfolio to provide greater returns to shareholders.



Growth Initiatives.

Our Leadership Agenda targets investments in faster-growing markets and businesses, promoting the growth of these high-potential businesses in the Company's portfolio while managing our more mature businesses to generate maximum levels of profits and cash flow.

Among our rapidly growing - or springboard - businesses, Electronic Materials now produces more than $200 million in annual revenue, up from $90 million at the beginning of 1999, and is well positioned to become an even more significant factor in our overall performance. As long as consumers continue to demand computers, wireless communications devices, cellular phones, automotive electronics, smart toys and other electronic products, manufacturers will continue to turn to Ferro for materials used in electronic components for those products.

The pharmaceutical market is another long-term growth opportunity. Our Performance and Fine Chemicals business is capitalizing on the trend of Pharmaceutical companies to outsource chemical production. It is a market with high profitability, clear differentiation of product, patent protection and other barriers to entry. Pharmaceutical manufacturers place a high premium on speed to market, which Ferro provides. We are building this business around key strengths and capabilities, such as the manufacture of high-potency chemicals for pharmaceuticals, to serve niche markets based on differentiated technology.




Acquisitions Broaden Product Lines.

Acquisitions are playing a major role in Ferro's growth and in reshaping our portfolio. In 2000, we completed the integration of Advanced Polymer Compounding (APC) and TAM Ceramics Incorporated (TAM), both of which were acquired the previous year. The APC acquisition has broadened our product line in plastic compounding, while the addition of TAM has helped solidify our leadership as a supplier of ceramic materials for the electronics industry.

Additionally, we announced three important acquisitions in the past year. With the purchase of the Polymer Modifiers business, we have added new technologies to the previously existing strengths of our Polymer Additives business. Our acquisition of Pfanstiehl Laboratories, Inc., enhances our capabilities in manufacturing chemicals for use in the pharmaceuticals industry. And our most recent acquisition, EMCA-Remex, complements our existing product line in Electronic Materials as we continue to build that business.

Over the past two years, acquisitions have added approximately $275 million to our annual base revenue.

Also, as part of our effort to reshape our portfolio to focus on the best opportunities for our Company, we completed the sale of the Pyro-Chek flame retardant business in June 2000.


< turn page >